Showing results (141-150 of 215) with videos related to
Sort By:
Pageof 22
Journal of Alzheimer'S Disease : JAD|March 28, 2022
Association Between Use of Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors and Cognitive Function in a Longitudinal Study of Patients with Type 2 DiabetesSerena Low, Kiat Sern Goh, Tze Pin Ng, et al.Diabetes/Metabolism Research and Reviews|June 9, 2018
Association of circulating proinflammatory marker, leucine-rich-α2-glycoprotein (LRG1), following metabolic/bariatric surgerySharon Li Ting Pek, Anton Kui Sing Cheng, Michelle Xueqin Lin, et al.Diabetes Research and Clinical Practice|August 12, 2019
Association between gain in adiposity and diabetic kidney disease worsening in type 2 diabetes is mediated by deteriorating glycaemic control: A 3-year follow-up analysisAngela Mei Chung Moh, Jiexun Wang, Clara Tan, et al.Journal of Alzheimer'S Disease : JAD|May 22, 2025
Double product is longitudinally associated with reduced cognitive function in type 2 diabetes with insights from cross-lagged panel analysis and mediation by leucine-rich α-2-glycoprotein 1Serena Low, Angela Moh, Bhuvaneswari Pandian, et al.Journal of Diabetes|November 21, 2017
Long-term outcomes of patients with type 2 diabetes attending a multidisciplinary diabetes kidney disease clinicSerena Low, Su Chi Lim, Jiexun Wang, et al.Journal of Lipid Research|May 4, 2024
Association of plasma ceramide with decline in kidney function in patients with type 2 diabetesResham L Gurung, Yiamunaa M, Wai Kin Tham, et al.European Journal of Preventive Cardiology|May 27, 2014
Chronic kidney disease, cardiovascular disease and mortality: A prospective cohort study in a multi-ethnic Asian populationCynthia C Lim, Boon Wee Teo, Peng Guan Ong, et al.Obesity (Silver Spring, Md.)|November 24, 2020
Correlation of Telomere Length in Adipose Tissue and Leukocytes and its Association with Postsurgical Weight LossResham L Gurung, Yiamunaa M, Angela Mei Chung Moh, et al.Diabetes Care|December 14, 2022
Urine Leucine-Rich α-2 Glycoprotein 1 (LRG1) Predicts the Risk of Progression to End-Stage Kidney Disease in Patients With Type 2 DiabetesJian-Jun Liu, Sylvia Liu, Jiexun Wang, et al.Diabetes & Metabolism|May 2, 2025
Methylamine metabolites and progression to kidney failure in type 2 diabetes: An Asian and European prospective studyPierre-Jean Saulnier, Jian-Jun Liu, Mikael Croyal, et al.Pageof 22